Robert (Bob) H. Underwood, PhD, helps clients achieve business objectives by drawing on his extensive experience establishing US and international intellectual property (IP) rights and identifying and evaluating third-party IP risks. He focuses his practice on the life sciences and chemical industries, including biologic and small-molecule pharmaceuticals and diagnostics, vaccines, medical devices, food science and nutritional supplements, agricultural technology, renewable and clean chemical technology, organic chemistry, polymers and catalysts.
Bob represents corporate companies of all sizes, from start-ups to mature multinationals, nonprofits and universities, as well as venture capital and private equity investors. He regularly assists clients with the following matters:
Bob also assists clients with product planning matters, patent lifecycle management, and the acquisition and divestment of intellectual property assets. He has experience with contentious IP matters, including patent interferences and oppositions, and pre-litigation planning.
Bob has prior experience as visiting scientist at the Basel Institute for Immunology in Switzerland and as a research associate at Brigham and Women’s Hospital in Boston. He earned his doctoral degree in immunology and his bachelor’s degree in biology.